![Haibo Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Haibo Wang
Corporate Officer/Principal presso HARPOON THERAPEUTICS, INC.
Posizioni attive di Haibo Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2023 | - |
Storia della carriera di Haibo Wang
Precedenti posizioni note di Haibo Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hummingbird Bioscience Pte Ltd.
![]() Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Corporate Officer/Principal | - | - |
Formazione di Haibo Wang
The Johns Hopkins University | Graduate Degree |
Tsinghua University | Undergraduate Degree |
Duke University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Singapore | 2 |
Cina | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 4 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Harpoon Therapeutics, Inc.
![]() Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Hummingbird Bioscience Pte Ltd.
![]() Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Commercial Services |
- Borsa valori
- Insiders
- Haibo Wang
- Esperienza